William H Matsui

Author PubWeight™ 16.78^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up.	Blood	2009	2.25
2	Association of Foxp3 regulatory gene expression with graft-versus-host disease.	Blood	2004	2.20
3	Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.	Biol Blood Marrow Transplant	2010	2.17
4	Cancer stem cells: are we missing the target?	J Natl Cancer Inst	2004	1.72
5	Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia.	Leuk Lymphoma	2012	1.57
6	A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model.	Mol Cancer Ther	2010	1.34
7	Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma.	Blood	2012	1.23
8	Strategies to eliminate cancer stem cells: clinical implications.	Eur J Cancer	2006	1.02
9	Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions.	Biol Blood Marrow Transplant	2006	0.99
10	Enhanced cytotoxicity of rituximab following genetic and biochemical disruption of glycosylphosphatidylinositol anchored proteins.	Leuk Lymphoma	2004	0.89
11	Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF.	Leuk Res	2010	0.87
12	Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistance.	J Clin Invest	2016	0.80
13	Cancer stem cells: A nuanced perspective.	Medicine (Baltimore)	2016	0.75